Small Cap📈 ASX: RAD
Radiopharm Theranostics Limited (ASX: RAD)
Published 6 February 2026PG Weekly Pick
Radiopharm Theranostics Limited
ASX: RAD
Radiopharm Theranostics Limited is a research-focused biotechnology company engaged in pre-clinical and clinical development. It specialises in creating radiopharmaceutical products for both diagnostic and therapeutic applications, targeting diseases with significant unmet medical needs. Founded by Paul A. Hopper in 2021, the company is headquartered
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
PG Weekly Pick
A$100.00
Already a subscriber?
Sign in to read this report.
Required subscription
PG Weekly Pick
Receive one high-conviction ASX stock idea every week, backed by detailed research, risk analysis, and a clear investment thesis designed to help you focus on quality opportunities.
- ✓ One Premium ASX Stock Pick Weekly
- ✓ Delivered Every Friday
- ✓ Buy / Hold / Sell Guidance & Risk Rating
- ✓ Full Historical Pick Access
A$100.00/ 1 months
Risk:High
Subscribe Now →
